Who owns PMV PHARMACEUTICALS INC?
- Ticker: PMVP
- CUSIP Number: 69353y103
Tip: Access positions for across all investors
Analyze quarterly positions in Pmv Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pmv Pharmaceuticals stock
Who bought or sold PMV PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 5.3M | $7.1M | 0% | Jun 2026 |
|
| Tang Capital Management | 4.2M | $5.7M | 0% | Jun 2026 |
|
| Sio Capital Management | 2.6M | $3.5M | -14% | Jun 2026 |
|
| Euclidean Capital | 2.6M | $3.5M | 0% | Jun 2026 |
|
| Adage Capital Partners GP | 2.4M | $3.2M | 27% | Jun 2026 |
|
| Acadian Asset Management | 2.2M | $3.0M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 2.0M | $2.7M | 2% | Jun 2026 |
|
| Arrowpoint Asset Management | 2.0M | $2.6M | -32% | Jun 2026 |
|
| Two Sigma Investments | 2.0M | $2.6M | 4% | Jun 2026 |
|
| Eversept Partners | 1.9M | $2.5M | -19% | Jun 2026 |
|
| BlackRock | 920k | $1.2M | 5% | Jun 2026 |
|
| Morgan Stanley | 864k | $1.1M | 774% | Mar 2026 |
|
| Stonepine Capital Management | 536k | $718k | -24% | Jun 2026 |
|
| Geode Capital Management | 473k | $635k | -5% | Jun 2026 |
|
| Aldebaran Capital | 467k | $626k | -1% | Jun 2026 |
|
| Bridgeway Capital Management | 429k | $575k | 0% | Jun 2026 |
|
| BIT Capital GmbH | 408k | $546k | 230% | Jun 2026 |
|
| Verdad Advisers | 362k | $486k | 101% | Jun 2026 |
|
| Walleye Trading Advisors | 336k | $450k | 0% | Jun 2026 |
|
| Assenagon Asset Management | 330k | $442k | -9% | Jun 2026 |
|
| Marshall Wace | 322k | $431k | -26% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 255k | $341k | -15% | Jun 2026 |
|
| Citadel Advisors | 250k | $335k | 93% | Jun 2026 |
|
| Bank of America Corporation | 240k | $322k | 0% | Jun 2026 |
|
| ADAR1 Capital Management | 201k | $269k | -13% | Jun 2026 |
|
| State Street Corporation | 183k | $227k | 0% | Mar 2026 |
|
| Rbf Capital | 162k | $217k | 0% | Jun 2026 |
|
| Goldman Sachs Group | 137k | $184k | 19% | Jun 2026 |
|
| MAI Wealth Advisors | 133k | $178k | 100% | Jun 2026 |
|
| Rangeley Capital | 99k | $133k | 48% | Jun 2026 |
|
| Northern Trust | 93k | $125k | -19% | Jun 2026 |
|
| Ikarian Capital | 89k | $119k | 0% | Jun 2026 |
|
| Jacobs Levy Equity Management | 71k | $95k | -61% | Jun 2026 |
|
| Pnc Financial Services | 68k | $91k | -1% | Jun 2026 |
|
| Quadrature Capital | 62k | $83k | 1% | Jun 2026 |
|
| Jane Street | 57k | $76k | -54% | Jun 2026 |
|
| Seven Fleet Capital Management | 54k | $72k | -16% | Jun 2026 |
|
| Hrt Financial | 51k | $67k | 100% | Jun 2026 |
|
| Accurate Wealth Management | 50k | $62k | 0% | Jun 2026 |
|
| Algert Coldiron Investors | 40k | $53k | -4% | Jun 2026 |
|
| Cooper/haims Advisors | 39k | $52k | 100% | Jun 2026 |
|
| Susquehanna International | 38k | $50k | 100% | Jun 2026 |
|
| Connor, Clark & Lunn Investment Management | 33k | $44k | 0% | Jun 2026 |
|
| Squarepoint Ops | 32k | $43k | 16% | Jun 2026 |
|
| Hsbc Holdings | 31k | $41k | 0% | Jun 2026 |
|
| Barclays | 28k | $37k | 1% | Jun 2026 |
|
| Boothbay Fund Management | 27k | $36k | 0% | Jun 2026 |
|
| Vanguard Global Advisers | 22k | $29k | 0% | Jun 2026 |
|
| Citigroup | 19k | $24k | 100% | Mar 2026 |
|
| Pathstone Holdings | 18k | $23k | 0% | Jun 2026 |
|
| CI Private Wealth | 15k | $20k | 0% | Jun 2026 |
|
| Sand Hill Advisors | 13k | $17k | 0% | Jun 2026 |
|
| Independent Advisor Alliance | 13k | $17k | 0% | Jun 2026 |
|
| Ohio Pers | 10k | $14k | -48% | Jun 2026 |
|
| Deerfield Management Company | 8.8k | $12k | 0% | Jun 2026 |
|
| Silver Grove Financial Group | 5.1k | $6.8k | 0% | Jun 2026 |
|
| Tower Research Capital | 1.1k | $1.4k | -22% | Jun 2026 |
|
| Jones Financial Companies, L.L | 1.0k | $1.2k | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 518.00 | $694.016400 | -4% | Jun 2026 |
|
| UBS Group | 361.00 | $483.992700 | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 214.00 | $275.995800 | 100% | Jun 2026 |
|
| Group One Trading | 90.00 | $120.996000 | 0% | Jun 2026 |
|
| Royal Bank of Canada | 76.00 | $0 | -92% | Jun 2026 |
|
| Caitong International Asset Management | 18.00 | $23.999400 | 500% | Jun 2026 |
|
Who sold out of Pmv Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Longaeva Partners | Mar 2026 | 552k | $685k |
| Evoke Wealth | Mar 2026 | 133k | $165k |
| Velan Capital Investment Management | Mar 2026 | 73k | $91k |
| Point72 Asset Management | Mar 2026 | 21k | $26k |
| GSA Capital Partners | Mar 2026 | 15k | $19k |
| Virtu Financial | Mar 2026 | 14k | $17k |
| Ameriprise Financial | Mar 2026 | 13k | $16k |
| Gts Securities | Mar 2026 | 10k | $12k |
| Simplex Trading | Mar 2026 | 8.2k | $10k |